MK-677 (Ibutamoren) and Acetaminophen Interaction: What You Need to Know
A guide to the MK-677 (ibutamoren) and acetaminophen drug interaction, covering hepatic toxicity overlap, CYP enzyme effects, monitoring, dosing, and patient counseling.
Mk 677: Drug Interactions
18 source-based articles maintained by the HealthRX.com Editorial Team.
18articles
3topic areas covered
Jul 10, 2025latest review
Mk 677: Drug Interactions library
Showing 18 of 18 clinical reviews.
MK-677 (Ibutamoren) and Apixaban Interaction: What Clinicians and Patients Need to Know
A clinical review of the MK-677 (ibutamoren) and apixaban drug interaction, covering CYP3A4 and P-glycoprotein pathways, pharmacodynamic risks, monitoring parameters, and dose-adjustment guidance.
MK-677 (Ibutamoren) and Bupropion Interaction: What Clinicians and Patients Need to Know
A clinical review of the MK-677 (ibutamoren) and bupropion drug interaction, covering CYP2D6 metabolism, seizure-threshold concerns, blood glucose effects, and monitoring recommendations.
MK-677 (Ibutamoren) and Cannabis: Full Interaction Profile
A guide covering the MK-677 and cannabis drug interaction profile, including pharmacodynamic overlaps, appetite amplification, blood glucose effects, and practical safety guidance.
MK-677 (Ibutamoren) and Clopidogrel Interaction: CYP2C19 Risk, Monitoring, and Clinical Guidance
Can you take MK-677 (ibutamoren) with clopidogrel? This guide covers the CYP2C19-mediated interaction, antiplatelet efficacy concerns, monitoring parameters, and dose-adjustment strategies.
MK-677 (Ibutamoren) and Diphenhydramine Interaction: Risks, Mechanisms, and Clinical Guidance
A cautious, mechanism-based review of combining MK-677 (ibutamoren) with diphenhydramine, covering sedation overlap, anticholinergic burden, metabolic effects, and what remains unverified.
MK-677 (Ibutamoren) and Gabapentin Interaction: What You Need to Know
A clinical deep-dive into the pharmacodynamic and pharmacokinetic interaction between MK-677 (ibutamoren) and gabapentin, covering sedation risk, renal overlap, monitoring parameters, and patient counseling for anyone combining these compounds.
MK-677 (Ibutamoren) and Metformin Interaction: What Clinicians and Patients Should Know
A clinical review of the pharmacodynamic interaction between MK-677 (ibutamoren) and metformin, covering glucose metabolism effects, monitoring protocols, and evidence-based risk assessment.
MK-677 (Ibutamoren) and Nicotine: Interaction Profile, Risks, and Clinical Guidance
A cautious review of what is known, plausible, and unestablished about combining MK-677 (ibutamoren) with nicotine, covering shared metabolic and cardiovascular risk pathways and what still needs primary-source verification.
MK-677 (Ibutamoren) and NSAIDs (Ibuprofen, Naproxen): Interaction Risks, Mechanisms, and Clinical Guidance
A analysis of the MK-677 (ibutamoren) and NSAID interaction, covering GI, renal, and metabolic overlap risks with monitoring and dose-adjustment guidance.
MK-677 (Ibutamoren) and Opioids Interaction: Risks, Mechanisms, and Clinical Guidance
Clinical analysis of the MK-677 (ibutamoren) and opioid (oxycodone, hydrocodone, tramadol) interaction including CNS depression risk, CYP3A4 overlap, monitoring parameters, and dose-adjustment strategies.
MK-677 (Ibutamoren) and Prednisone Interaction: Risks, Monitoring, and Clinical Guidance
A analysis of the pharmacodynamic interaction between MK-677 (ibutamoren) and prednisone, covering glucose dysregulation, bone density concerns, immunosuppression overlap, and monitoring protocols.
MK-677 (Ibutamoren) and Pregabalin Interaction: Risks, Mechanisms, and Clinical Guidance
Can you take MK-677 (ibutamoren) with pregabalin? Learn about the pharmacodynamic overlap, sedation risk, metabolic effects, monitoring requirements, and dose-adjustment strategies for this combination.
MK-677 (Ibutamoren) and Simvastatin Interaction: What Patients and Clinicians Need to Know
A clinical deep-dive into the pharmacokinetic and pharmacodynamic interaction between MK-677 (ibutamoren) and simvastatin, including CYP3A4 mechanisms, rhabdomyolysis risk, monitoring parameters, and dose-adjustment guidance.
MK-677 (Ibutamoren) and SSRIs (Sertraline, Escitalopram): Interaction Risk, Safety, and Monitoring
Can you take MK-677 (ibutamoren) with SSRIs like sertraline or escitalopram? Review the pharmacokinetic and pharmacodynamic interaction profile, serotonin syndrome risk, blood sugar effects, and clinical monitoring recommendations.
MK-677 (Ibutamoren) and Tadalafil Interaction: Safety, Mechanisms, and Clinical Guidance
A clinical review of the MK-677 (ibutamoren) and tadalafil drug interaction, covering CYP3A4 metabolism overlap, pharmacodynamic risks, blood pressure effects, and monitoring recommendations.
MK-677 (Ibutamoren) and Testosterone Interaction
Clinical review of the MK-677 (ibutamoren) and testosterone interaction, covering pharmacodynamic overlap, safety monitoring, polycythemia risk, lipid effects, and evidence-based dosing guidance.
MK-677 (Ibutamoren) Vaccine Interaction Profile
A guide to MK-677 (ibutamoren) and vaccine interactions, covering immunomodulatory mechanisms, GH/IGF-1 effects on vaccine response, alcohol interactions, and practical dosing guidance.
